Answers are grounded in this paper and cite their sources.
Drug delivery carriers with a high drug loading capacity and biocompatibility, especially for controlled drug release, are urgently needed due to the side effects and frequently dose in the traditional therapeutic method. In our work, a Zr‐based metal–organic framework named ZJU‐801, which is isoreticular with NU‐801, has been designed and further demonstrated as an excellent drug delivery system (DDS) with a high drug loading of 41.7 %. Such a high drug loading capacity may be ascribed to the appropriate match of the size and the large pore volume of this kind of Zr MOF material. Compared with DS@NU‐801, this DDS has successfully achieved on‐command heating‐activated drug release, which was probably attributed to the bulkier ligand, the better stability, and the intense π–π interaction between ZJU‐801 and diclofenac sodium (DS) demonstrated comprehensively by SEM, powder X‐ray diffraction (PXRD), FTIR and 13 C solid‐state NMR spectroscopy as well as computer simulations. It is worth noting that premature drug release was avoided effectively without any complicated post‐modifications. The low cytotoxicity and good biocompatibility of our DDS were certificated by the in vitro favorable results from an MTT assay, a WST‐1 assay, and confocal microscopy imaging.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: